318
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Carbapenem-Resistant Klebsiella pneumoniae: Diversity, Virulence, and Antimicrobial Resistance

, ORCID Icon, , ORCID Icon, , , , & show all
Pages 6177-6187 | Received 30 Aug 2022, Accepted 13 Oct 2022, Published online: 26 Oct 2022

References

  • Abd El-Aziz NK, Abd El-Hamid MI, Bendary MM, El-Azazy AA, Ammar AM. Existence of vancomycin resistance among methicillin resistant S. aureus recovered from animal and human sources in Egypt. Slov Vet Res. 2018;55:221–230.
  • Bendary MM, Solyman SM, Azab MM, Mahmoud NF, Hanora AM. Genetic diversity of multidrug resistant Staphylococcus aureus isolated from clinical and non clinical samples in Egypt. Cell Mol Biol. 2016;62(10):55.
  • Ghaly M, Shaheen A, Bouhy A, Bendary M. Alternative therapy to manage otitis media caused by multidrug-resistant fungi. Arch Microbiol. 2020;1:10.
  • Bengoechea JA, Sa-Pessoa J. Klebsiella pneumoniae infection biology: living to counteract host defences. FEMS Microbiol Rev. 2019;43:123–144. doi:10.1093/femsre/fuy043
  • Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323–2329. doi:10.1001/jama.2009.1754
  • Abdulallh AK, Tawfick MM, El-Manakhly AR, El-Kholy A. Carbapenem-resistant gram-negative bacteria associated with catheter-related bloodstream infections in three intensive care units in Egypt. Eur J Clin Microbiol Infect Dis. 2018;37:1647–1652. doi:10.1007/s10096-018-3294-7
  • Qurshi ZA, Paterson DL, Potoski BA, Kilayko MC, Sandovsky G, Sordillo E. Treatment outcome 478 of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of 479 combination antimicrobial regimens. Antimicrob Agents Chemother. 2012;56:2108–2113. doi:10.1128/AAC.06268-11
  • Zhang Y, Guo LY, Song WQ, Wang Y, Dong F, Liu G. Risk factors for carbapenem-resistant K pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients. BMC Infect Dis. 2018;18:248. doi:10.1186/s12879-018-3160-3
  • Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785–796. doi:10.1016/S1473-3099(13)70190-7
  • Yao B, Xiao X, Wang F, Zhou L, Zhang X, Zhang J. Clinical and molecular characteristics of multi-clone carbapenem-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in a tertiary hospital in Beijing China. Int J Infect Dis. 2015;37:107–112. doi:10.1016/j.ijid.2015.06.023
  • Zhang Y, Zhao C, Wang Q, Wang X, Chen H, Li H. High prevalence of hypervirulent Klebsiella pneumoniae infection in China: geographic distribution clinical characteristics and antimicrobial resistance. Antimicrob Agents Chemother. 2016;606:115–6120.
  • Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev. 2016;80(3):629–661. doi:10.1128/MMBR.00078-15
  • Talaat M, EL-Shokry M, EL-Kholy J, et al. National surveillance of health case-associated infections in Egypt: developing sustainable program in a resource-limited country. An J Infection Control. 2016;44(11):1296–1301. doi:10.1016/j.ajic.2016.04.212
  • Zavascki AP, Carvalhaes CG, Picao RC, Gales AC. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Rev Anti Infect Ther. 2010;8(1):71–93. doi:10.1586/eri.09.108
  • Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med. 2010;362(19):1804–1813. doi:10.1056/NEJMra0904124
  • Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev. 2006;19(2):382–402. doi:10.1128/CMR.19.2.382-402.2006
  • Ferreira RL, Silva BM, Rezende GS, et al. High prevalence of multidrug-resistant Klebsiella pneumoniae harboring several virulence and β-lactamase encoding genes in a Brazilian intensive care unit. Front Microbiol. 2009;22:1.
  • Kaczmarek FM, Dib-Hjj F, Shang W, Gootz TD. High-Level Carbapenem Resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla ACT-1 β-Lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE. Antimicrob Agents Chemother. 2006;50(10):3396–3406. doi:10.1128/AAC.00285-06
  • Khaertynov K, Anokhin VA, Rizvanov AA, et al. Virulence factors and antibiotic resistance of Klebsiella pneumoniae strains isolated from neonates with sepsis. Front Med. 2018;2018:5225.
  • Wasfi R, Elkhatib WF, Ashour HM. Molecular typing and virulence analysis of multidrug resistant Klebsiella pneumoniae clinical isolates recovered from Egyptian hospitals. Sci Rep. 2016;2016:638929.
  • Ashour HM, El-Sharif A. Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients. J Transl Med. 2009;2009:714.
  • Ahmadi M, Ranjbar R, Behzadi P, Mohammadian T. Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella Pneumoniae. Expert Rev Anti Infect Ther. 2022;20(3):463–472. doi:10.1080/14787210.2022.1990040
  • Behzadi P, Urbán E, Matuz M, Benkő R, Gajdács M. The role of gram-negative bacteria in urinary tract infections: current concepts and therapeutic options. Adv Exp Med Biol. 2021;1323:35–69.
  • Issakhanian L, Behzadi P. Antimicrobial agents and urinary tract infections. Curr Pharm Des. 2019;25(12):1409–1423. doi:10.2174/1381612825999190619130216
  • Elmer K, Stephen A, William J, Gary P, Paul S, Gall W. Koneman’s Color Atlas and Textbook of Diagnostic Microbiology. 6th ed. London UK: Lippincott Williams and Wilkins; 2006.
  • Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. Color Atlas and Textbook of Diagnostic Microbiology. 5th ed. USA: Lippncott-Raven Publishers; 1997.
  • Clinical and Laboratory Standards Institute. M100-S25, Performance Standards for Antimicrobial Susceptibility Testing, 28th Informational Supplement. Wayne PA: CLSI; 2018.
  • Noyal MC, Menezes GA, Sujatha BN, Harish S, Parija SC. Simple screening tests for detection of carbapenemases in clinical isolates of non-fermentative gram-negative bacteria. Indian J Med Res. 2009;129(6):707–712.
  • Maina D, Revathi G, Kariuki S, Ozwara H. Genotypes and cephalosporin susceptibility in extended-spectrum beta-lactamase producing Enterobacteriaceae in the community. J Infect Dev Ctries. 2012;15:470–477.
  • Poirel L, Walsh TR, Cuvillier TR, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Infect Dis. 2011;70:119–123.
  • Siu LK, Fung C-P, Chang F-Y, et al. Molecular typing and virulence analysis of serotype K1 Klebsiella pneumoniae strains isolated from liver abscess patients and stool samples from noninfectious subjects in Hong Kong, Singapore, and Taiwan. J Clin Microbiol. 2011;49(11):3761–3765. doi:10.1128/JCM.00977-11
  • Yu WL, Ko WC, Cheng KC, Lee HC, Ke DS, Lee CC. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan. Clin Infect Dis. 2006;42(10):1351–1358. doi:10.1086/503420
  • Ghaly MF, Nasr ZM, Abousaty AI, et al. Alternative and complementary therapies against foodborne salmonella infections. Antibiotics. 2021;10(12):1453. doi:10.3390/antibiotics10121453
  • Ammar AM, Abd El-Hamid MI, El-Malt RMS, et al. Molecular detection of fluoroquinolone resistance among multidrug- extensively drug- and pan-drug-resistant campylobacter species in Egypt. Antibiotics. 2021;10(11):1342. doi:10.3390/antibiotics10111342
  • Bendary MM, Ibrahim D, Mosbah RA, et al. Thymol nanoemulsion: a new therapeutic option for extensively drug resistant foodborne pathogens. Antibiotics. 2020;10(1):25. doi:10.3390/antibiotics10010025
  • Ghaith DM, Zafer MM, Said HM, et al. Genetic diversity of carbapenem-resistant Klebsiella pneumoniae causing neonatal sepsis in intensive care unit, Cairo, Egypt. Eur J Clin Microbiol Infect Dis. 2019;39(3):583–591. doi:10.1007/s10096-019-03761-2
  • Candan ED, Aksöz N. Klebsiella pneumoniae: characteristics of carbapenem resistance and virulence factors. Acta Biochim Pol. 2015;62:867‐874.
  • Chander A, Shrestha CD. Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu Nepal. BMC Res Notes. 2013;25(1):487. doi:10.1186/1756-0500-6-487
  • Ranjbar R, Fatahian KA, Chehelgerdi M. Molecular characterization serotypes and phenotypic and genotypic evaluation of antibiotic resistance of the Klebsiella pneumoniae strains isolated from different types of hospital-acquired infections. Infect Drug Resist. 2019;12:603‐611. doi:10.2147/IDR.S199639
  • El-Kholy A, Baseem H, Hall GS, Procop GW, Longworth DL. Antimicrobial resistance in Cairo Egypt 1999–2000: a survey of five hospitals. J Antimicrob Chemother. 2003;51:625–630. doi:10.1093/jac/dkg101
  • Fletcher S. Understanding the contribution of environmental factors in the spread of antimicrobial resistance Environ. Health Prev Med. 2015;20:243–252. doi:10.1007/s12199-015-0468-0
  • Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6:47.
  • Martin RM, Bachman MA. Colonization infection and the accessory genome of Klebsiella pneumonia. Front Cell Infect Microbiol. 2018;8:224. doi:10.3389/fcimb.2018.00224
  • Hayashi W, Iimura M, Soga E, et al. Presence of Colistin- and tigecycline-resistant Klebsiella pneumoniae ST29 in municipal wastewater influents in Japan. Microb Drug Resist. 2021;27:1433–1442. doi:10.1089/mdr.2020.0514
  • Rojas LJ, Salim M, Cober E, et al. Antibacterial resistance leadership group (2017) colistin resistance in carbapenem-resistant Klebsiella pneumoniae: laboratory detection and impact on mortality. Clin Infect Dis. 2017;64:711–718. doi:10.1093/cid/ciw805
  • Li-Chen M, Chi-Tai F, Cha-Ze L, Chia-Tung S, Jin-Town W. Genomic heterogeneity in Klebsiella pneumoniae strains is associated with primary pyogenic liver abscess and metastatic infection. J Infect Dis. 2005;192:117–128. doi:10.1086/430619
  • Khan A, Mutayyaba A, Bettina F, Eric S, Elizabeth D. Heterogeneity of Klebsiella pneumoniae clinical isolates obtained from Stony Brook University hospital. Open Forum Infect Dis. 2015;2:1813. doi:10.1093/ofid/ofv133.1363
  • Bendary MM, Abdel-Hamid MI, Alshareef WA, et al. Comparative analysis of human and animal E coli: serotyping antimicrobial resistance and virulence gene profiling. Antibiotics. 2022;11:552. doi:10.3390/antibiotics11050552
  • Elfaky MA, Abdel-Hamid MI, Khalifa E, et al. Innovative next-generation therapies in combating multi-drug-resistant and multi-virulent Escherichia coli isolates: insights from in vitro in vivo and molecular docking studies. Appl Microbiol Biotechnol. 2022;106:1691–1703. doi:10.1007/s00253-022-11781-w
  • Beceiro A, Tomás M, Bou G. Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clin Microbiol Rev. 2013;26:185–230. doi:10.1128/CMR.00059-12
  • Bendary MM, Solyman SM, Azab MM, Mahmoud NF, Hanora AM. Characterization of Methicillin resistant Staphylococcus aureus isolated from human and animal samples in Egypt. Cell Mol Biol. 2016;62:94–100.
  • Jin J, Sklar GE, Min-Sen OV, Chuen LS. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag. 2008;4:4269–4286.
  • Zheng B, Dai Y, Liu Y, et al. Molecular epidemiology and risk factors of carbapenem-resistant Klebsiella pneumoniae infections in Eastern China. Front Microbiol. 2017;13:1061. doi:10.3389/fmicb.2017.01061
  • Tumbarello M, Trecarichi EM, De-Rosa FG, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015;70:2133–2143. doi:10.1093/jac/dkv086
  • Zhou C, Jin L, Wang Q, et al. Bloodstream infections caused by carbapenem-resistant enterobacterales: risk factors for mortality antimicrobial therapy and treatment outcomes from a prospective multicenter study. Infect Drug Resist. 2021;24:731–742. doi:10.2147/IDR.S294282
  • Shao C, Wang W, Liu S, Zhang Z, Jiang M, Zhang F. Molecular epidemiology and drug resistant mechanism of carbapenem-resistant Klebsiella pneumoniae in elderly patients with lower respiratory tract infection. Front Public Health. 2021;20:669173. doi:10.3389/fpubh.2021.669173
  • Shi Y, Hu J, Liu P, et al. Ceftazidime–avibactam-based versus tigecycline-based regimen for the treatment of carbapenem-resistant Klebsiella pneumoniae-induced pneumonia in critically ill patients. Infect Dis Ther. 2021;10:2721–2734. doi:10.1007/s40121-021-00542-3